A DNA sequencing analysis associated Q192R polymorphism in the paraoxonase 1 gene with female infertility in Saudi women.
There is an association between Q192R polymorphism in the paraoxonase 1 (PON1) gene and female infertility in Saudi women, according to the results of a case-controlled study published in the Journal of King Saud University – Science. The research also suggested obesity may be linked to female infertility.
Infertility is reported to be one of the most common chronic health conditions and affects 15% of all couples worldwide, with female infertility accounting for 40% of all cases, according to one prior study on female infertility.
"Many causes of female infertility have been identified, with the majority of them being genetic abnormalities such as chromosomal defects or single gene mutations," the researchers noted.
This study included a total of 222 Saudi women, in which 122 were infertile and 100 were fertile. Cases of infertility were included if the woman had a history of infertility in her family and had also been trying to conceive for more than 2 to 3 years. Women with a regular menstrual cycle and ability to conceive without a family history of infertility were included in the fertile women control group.
Genomic DNA was extracted from all participants, and underwent a variety of tests, including quantified performed polymerase chain reaction, agarose gel run, and restriction fragment length polymorphism (RFLP) analysis.
According to the results, Q129R polymorphism confirms the allele (P = .003) and genetic association (QR v QQ; P = .001) with different modes of inheritances, including dominant and co-dominant models (P = .003). Furthermore, the researchers found an association between weight and Q192R polymorphism (P = .04), suggesting obesity may also be linked to female infertility.
Additional demographic data collected included the participant’s age, height, weight, and body mass index (BMI). Although the mean age between fertile (28.3±6.8) and infertile (32.7±5.9) women was not statistically significant (P = .0001), the researchers were able to identify a variation between weight (P = .006) and BMI in both groups (31.4±4.3) and in the controls (28.8±4.4; P = .00001). Weight was associated with elevated QQ genotypes (80.6±12.3) among 3 models of genotyping when compared with QR (78.4±12.6) and RR (71.8±10.8) genotypes.
In the fertile group, genotyping distribution was QQ (69%), QR (22%), and RR (9%). In the infertile group, it was QQ (47.5%), QR (40.2%), and RR (12.3%). Additionally, the Q allele was 80% more common than the R allele (20%) in the fertile group, whereas in the infertile group, the R allele was 70% more common than the Q allele (68%). Furthermore, when comparing groups, allele frequency was found to be associated with infertility (odds ratio [OR], 1.91; 95% CI, 1.23-2.96; P = .003). When compared to the homozygous QQ genotype, the Heterozygous genotype was associated with infertility (QR v QQ; OR, 2.65; 95% CI, 1.43-4.88; P = .001). Additionally, there was also an association between co-dominant models (OR, 1.41; 95% CI, 1.31-4.31; P = .003).
The results of this study align with prior studies that found a high variability in PON1 enzymes may be linked with various health issues, such as pregnancy loss and female infertility. The researchers recommend further studies in order to evaluate the potential genetic risk factors of interactions with additional PON1 polymorphisms.
“This study concludes as Q192R polymorphism was positively associated in this case-control study performed in the Saudi women diagnosed with female infertility,” wrote the researchers. “However, obesity factor might also be playing a role in the infertile women.”
Reference
Alshammary AF. Genetic association between Q192R polymorphism in the paraoxonase 1 gene and female infertility in the Saudi women: Validated using DNA sequencing analysis. Journal of King Saud University - Science. 2023;35(3):102567. doi:10.1016/j.jksus.2023.102567
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More
Addressing Maternal Mortality in Medicaid by Focusing on Mental Health
February 15th 2023On this episode of Managed Care Cast, we speak with Inland Empire Health Plan, a managed care plan serving more than 1.4 million residents on Medi-Cal in California, about a new maternal mental health program aimed at supporting new mothers, both before they give birth and afterward.
Listen
For National Women’s Health Week, One Company Emphasizes Cardiovascular Risk Management
May 10th 2022On this episode of Managed Care Cast, we speak with Joanne Armstrong, MD, MPH, vice president and chief medical officer for Women’s Health and Genomics at CVS Health, on the distinct pathophysiology of cardiovascular disease in women and how her own health experiences have influenced her perspective on cardiovascular disease management.
Listen
What We’re Reading: Historic Low of Uninsured; Youth Gender Treatments; Birth Control Recall
August 4th 2023A record low of 7.7% of Americans had no health insurance at the start of 2023; the American Academy of Pediatrics renewed its backing of gender care for children while requesting a research review; 2 lots of an oral contraceptive were recalled for possible reduction in effectiveness.
Read More
Lawyers were questioned in a federal lawsuit intending to overturn approval of a drug used for medication abortion; during the COVID-19 pandemic in 2021, US maternal mortality increased for the third year in a row; the Alzheimer’s Association is lobbying Congress to push for Medicare coverage of new Alzheimer drugs under early access.
Read More